Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
zilganersen
DRUG
2 trials
Sponsors
Ionis Pharmaceuticals, Inc.
Conditions
Alexander Disease
Phase 3
A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD)
Active, not recruiting
NCT04849741
Ionis Pharmaceuticals, Inc.
Alexander Disease
Start: 2021-06-01
End: 2034-07-01
Updated: 2026-08-21
Unknown Phase
Zilganersen Expanded Access Program for Individuals With Alexander Disease
NCT07487389
Ionis Pharmaceuticals, Inc.
Alexander Disease
Updated: 2026-03-23